These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32652826)

  • 1. Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA.
    Pang C; Wen L; Qin H; Zhu B; Lu X; Luo S
    J Cell Mol Med; 2020 Aug; 24(15):8452-8465. PubMed ID: 32652826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1/2/NFATc1 pathway.
    Hu W; Cai C; Li Y; Kang F; Chu T; Dong S
    FASEB J; 2022 Apr; 36(4):e22243. PubMed ID: 35224782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis.
    Ding D; Yan J; Feng G; Zhou Y; Ma L; Jin Q
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34738623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation.
    Bertuglia A; Lacourt M; Girard C; Beauchamp G; Richard H; Laverty S
    Osteoarthritis Cartilage; 2016 Mar; 24(3):555-66. PubMed ID: 26505663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis.
    Izawa T; Mori H; Shinohara T; Mino-Oka A; Hutami IR; Iwasa A; Tanaka E
    PLoS One; 2016; 11(4):e0154107. PubMed ID: 27123995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
    Dong Y; Liu H; Zhang X; Xu F; Qin L; Cheng P; Huang H; Guo F; Yang Q; Chen A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.
    Cui Z; Crane J; Xie H; Jin X; Zhen G; Li C; Xie L; Wang L; Bian Q; Qiu T; Wan M; Xie M; Ding S; Yu B; Cao X
    Ann Rheum Dis; 2016 Sep; 75(9):1714-21. PubMed ID: 26470720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
    Siebelt M; Waarsing JH; Groen HC; Müller C; Koelewijn SJ; de Blois E; Verhaar JA; de Jong M; Weinans H
    Bone; 2014 Sep; 66():163-70. PubMed ID: 24933343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD0325901, an ERK inhibitor, attenuates RANKL-induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways.
    Jiang T; Gong Y; Zhang W; Qiu J; Zheng X; Li Z; Yang G; Hong Z
    Bioorg Chem; 2023 Mar; 132():106321. PubMed ID: 36642020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.
    Guo H; Ding D; Wang L; Yan J; Ma L; Jin Q
    PLoS One; 2021; 16(12):e0261127. PubMed ID: 34914744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruboxistaurin maintains the bone mass of subchondral bone for blunting osteoarthritis progression by inhibition of osteoclastogenesis and bone resorption activity.
    Pang C; Wen L; Lu X; Luo S; Qin H; Zhang X; Zhu B; Luo S
    Biomed Pharmacother; 2020 Nov; 131():110650. PubMed ID: 32882584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity.
    Yao J; Li J; Zhou L; Cheng J; Chim SM; Zhang G; Quinn JM; Tickner J; Zhao J; Xu J
    J Cell Physiol; 2015 Jun; 230(6):1235-42. PubMed ID: 25363829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption.
    Ding D; Wang L; Yan J; Zhou Y; Feng G; Ma L; Yang Y; Pei X; Jin Q
    PLoS One; 2022; 17(7):e0271485. PubMed ID: 35900969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosmetin inhibits subchondral bone loss and indirectly protects cartilage in a surgically-induced osteoarthritis mouse model.
    Ding H; Ding H; Mu P; Lu X; Xu Z
    Chem Biol Interact; 2023 Jan; 370():110311. PubMed ID: 36563736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion.
    Fang C; Guo JW; Wang YJ; Li XQ; Zhang H; Cui J; Hu Y; Jing YY; Chen X; Su JC
    Acta Pharmacol Sin; 2022 May; 43(5):1299-1310. PubMed ID: 34381182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues.
    Chen W; Wang Q; Tao H; Lu L; Zhou J; Wang Q; Huang W; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):499-512. PubMed ID: 38439665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes.
    Kim GM; Kim J; Lee JY; Park MC; Lee SY
    Exp Mol Med; 2023 Dec; 55(12):2576-2585. PubMed ID: 38036734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
    Löfvall H; Newbould H; Karsdal MA; Dziegiel MH; Richter J; Henriksen K; Thudium CS
    Arthritis Res Ther; 2018 Apr; 20(1):67. PubMed ID: 29636095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.